India Glycols has completed an important restructuring exercise, with its three-way demerger becoming effective from September 1. The business will now be separated into focused entities covering specialty chemicals, spirits and biofuels, and biopharma.
Under the approved arrangement, shareholders are entitled to receive one share of IGL Spirits for every one India Glycols share held, and one share of Ennature Bio Pharma for every three India Glycols shares, subject to the scheme’s terms and record-date conditions.
The restructuring could help investors evaluate the three businesses separately and provide greater strategic focus to each segment. The record date for the share allotment is September 2, 2026.
